Sichuan Hebang Biotechnology Stock Current Ratio

Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

In accordance with the recently published financial statements, Sichuan Hebang Biotechnology has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Chemicals sector and about the same as Materials (which currently averages 0.0) industry. The current ratio for all China stocks is 100.0% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze Sichuan Hebang Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sichuan Hebang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sichuan Hebang Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Sichuan Hebang financial ratios help investors to determine whether Sichuan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sichuan with respect to the benefits of owning Sichuan Hebang security.